There are also potential links with SGX's product platform and opportunities for cross-selling, given Scientific Beta's relationships with more than 60 asset owners and asset managers, analyst Lim Rui Wen wrote.
"We believe SGX will continue to benefit from strong demand for risk management instruments, as it continues to execute growth strategies to build a multi-asset exchange," said Ms Lim.
日本 最新ニュース, 日本 見出し
Similar News:他のニュース ソースから収集した、これに似たニュース記事を読むこともできます。
ソース: YahooSG - 🏆 3. / 71 続きを読む »